ACADIA Pharmaceuticals Financial Statements
ACADIA Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
ACADIA Pharmaceuticals Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 7.6 | 8.1 | 11.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (62.7) | (49.0) | (35.8) |
| Total Net Income ($ mil.) | (56.4) | (45.0) | (34.1) |
| Diluted EPS (Net Income) | (1.60) | (1.61) | (1.55) |
ACADIA Pharmaceuticals Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.8 | 1.6 | 2.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (17.6) | (18.7) | (17.9) |
| Total Net Income ($ mil.) | (16.4) | (17.0) | (16.0) |
| Diluted EPS (Net Income) | (0.44) | (0.46) | (0.44) |
ACADIA Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 22.89 | 3.77 | 1.54 |
| Price/Earnings Ratio | -- | 15.99 | 15.14 |
| Price/Book Ratio | 1.48 | 2.70 | 1.46 |
| Price/Cash Flow Ratio | -- | 11.60 | 9.41 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed ACADIA Pharmaceuticals Financial Ratios
ACADIA Pharmaceuticals Competitive Intelligence
| AstraZeneca | Eli Lilly | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 29,559.0 | 18,633.5 | 48,418.0 |
| Employees | -- | 40,600 | 86,600 |
| Market Cap ($ mil.) | -- | 53,437.8 | 118,188.0 |
Competitive Landscape
